Table 2.
Comparison of periodontal treatment effects on glycemic control in patients with type 1 diabetes
|
Reference |
Study design |
Follow-up |
Periodontal therapy |
Metabolic control outcome measure |
Periodontal parameters assesseda |
Effects on metabolic control |
|
|
1a |
Aldridge et al. (study 1) 199511 |
RCT |
2 months |
41 T1DM subjects with gingivitis and early periodontitis Treatment group: oral hygiene instructions, scaling, correction of restoration margins, reinforcement at one month Control group: no treatment |
Glycated hemoglobin, fructosamine |
PI, BOP, PD |
Periodontal treatment showed no effect on glycated hemoglobin levels |
|
1b |
Aldridge et al. (study 2) 199511 |
RCT |
2 months |
23 subjects were recruited and divided into 2 groups Treatment group: oral hygiene instructions, scaling/root planing, extractions, root canal therapy Control group: no treatment |
Glycated hemoglobin |
PI, BOP, PD |
Periodontal treatment showed no effect on glycated hemoglobin levels |
|
2 |
Smith et al. 199612 |
Treatment study Non-RCT |
2 months |
Scaling and root planing using an ultrasonic scaler, curettes, oral hygiene instructions |
Glycated hemoglobin |
PD, CAL, GI Gingival fluid AST levels |
No significant change in glycated hemoglobin |
|
3 |
Westfelt et al. 199613 |
Treatment study Non-RCT |
5 years |
20 patients with diabetes, T1DM or T2DM, were recruited Patients received oral hygiene instruction, scaling and root planing, subgingival scaling and surgery at sites with BOP and PD >5 mm |
Glycated hemoglobin |
PI, GI |
The mean value of HbA1c between baseline and 24 months was not significantly different from 24 to 60 months |
|
4 |
Christgau et al. 199814 |
Treatment study, Non-RCT |
2 months |
20 T1DM (n = 7) or T2DM (n = 13) with periodontal disease Scaling and root planing, irrigation with chlorhexidine, oral hygiene instructions, extractions |
Glycated hemoglobin |
PI, Papilla bleeding index, BOP, PD, Probing attachment level (PAL) |
No changes in glycated hemoglobin |
|
5 |
Skaleric et al. 200415 |
RCT |
6 months |
20 patients with poorly controlled diabetes (HbA1c 7.5%) and periodontitis Presence of 4 teeth with 5 mm periodontal pockets and BOP The test group received scaling and root planing with minocycline microspheres (Arestin®) The control group received only scaling and root planing |
Glycated hemoglobin |
PI, GI, PD, CAL |
Demonstrated reduction in HbA1c levels in both groups, but the intergroup difference was not statistically significant |
|
6 |
Llambés et al. 200816 |
RCT |
3 months |
60 T1DM subjects with moderate to severe periodontitis Test group received scaling and root planing, chlorhexidine mouthwash, and doxycycline 100 mg for 15 days Control group: same treatment as test group but doxycycline was not given |
Glycated hemoglobin |
PI, BOP, PD, CAL |
No changes in glycosylated hemoglobin |
|
7 |
Tervonen et al. 200917 |
Non-RCT |
2 months |
Oral hygiene education, scaling, root planing, with or without periodontal surgery |
Glycated hemoglobin |
No improvement in glycemic control was reported by many subjects |
|
|
8 |
Buzinin et al. 201418 |
Non-RCT |
41 Malaysian subjects: 20 subjects were T1DM with chronic periodontal disease (test group) and 21 only chronic periodontal diseases Both groups received oral hygiene instructions and one session of full-mouth debridement |
Glycated hemoglobin |
PI, GI, PD, PAL |
No changes in HbA1c level in the test group |
|
|
9 |
Lopes et al. 201719 |
Non-RCT |
6 months |
70 patients with periodontitis; 3 groups Control group (n = 11): systemically healthy subjects Test-group 1 (n = 14): subjects with T1DM Test-group 2 (n = 27): subjects with T2DM Basic periodontal treatment, oral hygiene instructions, scaling and root planing, supportive therapy; additional 2 g amoxicillin as antibiotic prophylaxis 1 h before—for subjects with diabetes |
Glycated hemoglobin |
PI, BOP, PD, CAL |
Periodontal treatment was more effective for glycemic control in T1DM patients than in T2DM |
aPI: Plaque Index; GI: Gingival Index; BOP: bleeding on probing; PD: pocket depth; CAL: clinical attachment level